Larimar Therapeutics
Price & Volume
Stats
See moreOpen | $2.66 |
Previous Close | $2.54 |
Day Range | $2.62-$2.74 |
52W Range | $1.91-$6.42 |
Market Cap | $246.2M |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.92 |
News
See moreYahoo Finance • 3 months ago
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Yahoo Finance • 3 months ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
Yahoo Finance • 4 months ago
Larimar Therapeutics (LRMR) Submits Initial Module of BLA For Nomlabofusp Therapy
Yahoo Finance • 4 months ago
Larimar To Host Investor Event On Nomlabofusp Program On Monday, Stock Up
About
CEO | Dr. Carole S. Ben-Maimon M.D. |
CFO | Mr. Michael Celano CPA |
Address | Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 71 |